logo
Plus   Neg
Share
Email

Ligand Pharmaceuticals Inc Q2 adjusted earnings Beat Estimates

Below are the earnings highlights for Ligand Pharmaceuticals Inc (LGND):

-Earnings: -$14.42 million in Q2 vs. $73.16 million in the same period last year.
-EPS: -$0.74 in Q2 vs. $2.99 in the same period last year.
-Excluding items, Ligand Pharmaceuticals Inc reported adjusted earnings of $13.89 million or $0.68 per share for the period.
-Analysts projected $0.55 per share
-Revenue: $24.99 million in Q2 vs. $90.04 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT
>